Joanne M. Smallheer
DuPont
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Joanne M. Smallheer.
Journal of Medicinal Chemistry | 2014
Mimi L. Quan; Pancras C. Wong; Cailan Wang; Francis J. Woerner; Joanne M. Smallheer; Frank A. Barbera; Jeffrey M. Bozarth; Randi L. Brown; Mark R. Harpel; Joseph M. Luettgen; Paul E. Morin; Tara L. Peterson; Vidhyashankar Ramamurthy; Alan R. Rendina; Karen A. Rossi; Carol A. Watson; Anzhi Wei; Ge Zhang; Dietmar A. Seiffert; Ruth R. Wexler
Antithrombotic agents that are inhibitors of factor XIa (FXIa) have the potential to demonstrate robust efficacy with a low bleeding risk profile. Herein, we describe a series of tetrahydroquinoline (THQ) derivatives as FXIa inhibitors. Compound 1 was identified as a potent and selective tool compound for proof of concept studies. It exhibited excellent antithrombotic efficacy in rabbit thrombosis models and did not prolong bleeding times. This demonstrates proof of concept for the FXIa mechanism in animal models with a reversible, small molecule inhibitor.
Journal of Medicinal Chemistry | 2014
Jon J. Hangeland; Todd J. Friends; Karen A. Rossi; Joanne M. Smallheer; Cailan Wang; Zhong Sun; James R. Corte; Tianan Fang; Pancras C. Wong; Alan R. Rendina; Frank A. Barbera; Jeffrey M. Bozarth; Joseph M. Luettgen; Carol A. Watson; Ge Zhang; Anzhi Wei; Vidhyashankar Ramamurthy; Paul E. Morin; Gregory S. Bisacchi; Srinath Subramaniam; Piramanayagam Arunachalam; Arvind Mathur; Dietmar A. Seiffert; Ruth R. Wexler; Mimi L. Quan
Novel inhibitors of FXIa containing an (S)-2-phenyl-1-(4-phenyl-1H-imidazol-2-yl)ethanamine core have been optimized to provide compound 16b, a potent, reversible inhibitor of FXIa (Ki = 0.3 nM) having in vivo antithrombotic efficacy in the rabbit AV-shunt thrombosis model (ID50 = 0.6 mg/kg + 1 mg kg(-1) h(-1)). Initial analog selection was informed by molecular modeling using compounds 11a and 11h overlaid onto the X-ray crystal structure of tetrahydroquinoline 3 complexed to FXIa. Further optimization was achieved by specific modifications derived from careful analysis of the X-ray crystal structure of the FXIa/11h complex. Compound 16b was well tolerated and enabled extensive pharmacologic evaluation of the FXIa mechanism up to the ID90 for thrombus inhibition.
Tetrahedron Letters | 1992
Mark A. Wuonola; Joanne M. Smallheer
Abstract N-Methyl-N-propargylimidazole-5-carboxamide undergoes thermal intramolecular Diels-Alder reaction to give the title compound. A related reaction of the corresponding sydnone system is also described.
Tetrahedron Letters | 1991
Mark A. Wuonola; Joanne M. Smallheer; J.M. Read; Joseph C. Calabrese
Abstract N -methyl- N -propargyl and N -methyl- N -allylisoquinoline-1-carboxamides undergo facile intramolecular Diels-Alder reactions to give fused N -methyl-γ-lactams.
Journal of Medicinal Chemistry | 2010
Donald J. P. Pinto; Joanne M. Smallheer; Daniel L. Cheney; Robert M. Knabb; Ruth R. Wexler
Proceedings of the National Academy of Sciences of the United States of America | 2000
David Cue; Sarka O. Southern; Peter J. Southern; Jadhar Prabhakar; William Lorelli; Joanne M. Smallheer; Shaker A. Mousa; P. Patrick Cleary
Journal of Medicinal Chemistry | 2000
William J. Pitts; John Wityak; Joanne M. Smallheer; A. Ewa Tobin; James W. Jetter; Jennifer S. Buynitsky; Patricia P. Harlow; Kimberly A. Solomon; Martha H. Corjay; Shaker A. Mousa; and Ruth R. Wexler; Prabhakar K. Jadhav
Archive | 2001
Irina C. Jacobson; Ruth R. Wexler; Suanne Nakajima; Mimi L. Quan; Shuaige Wang; Joanne M. Smallheer; Jennifer X. Qiao
Archive | 2004
Joanne M. Smallheer; Mimi L. Quan; Shuaige Wang; Gregory S. Bisacchi
Archive | 1996
Matthew E. Voss; Prabhakar K. Jadhav; Joanne M. Smallheer; Douglas G. Batt; William J. Pitts; John Wityak